Search

Search Results
Results 5261 - 5270 of 17261 for Active treatment
  • News - 4 Jun 2026
    Smartphone-based heart rhythm monitoring from home can reduce same-day cancellations and help save significant healthcare resources ahead of planned electrical cardioversion in patients with atrial...
  • Drug - 4 Jun 2026
    Consumer Medicine Information (CMI) about Symdeko intended for persons living in Australia.
  • Drug - 3 Jun 2026
    Consumer Medicine Information (CMI) about Wezlana intended for persons living in Australia.
  • Drug - 1 Jun 2026
    Consumer Medicine Information (CMI) about Itracap intended for persons living in Australia.
  • Drug - 29 May 2026
    Consumer Medicine Information (CMI) about Epilim IV intended for persons living in Australia.
  • News - 28 May 2026
    A major international phase III clinical trial, led by Queen Mary University of London, has found that ocrelizumab – a medication already prescribed to some patients with MS – significantly slows...
  • Drug - 27 May 2026
    Consumer Medicine Information (CMI) about Scemblix intended for persons living in Australia.
  • News - 26 May 2026
    Researchers have solved a long-standing mystery about why physical forces slow cancer growth – and the answer could reshape how the disease is treated.
  • Drug - 26 May 2026
    Consumer Medicine Information (CMI) about Plaquenil intended for persons living in Australia.
  • Drug - 25 May 2026
    Consumer Medicine Information (CMI) about Cenrifki intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.